Inovotion Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Inovotion General Information
Description
Operator of a preclinical oncology research company intended to support cancer drug development. The company provides in vivo oncology efficacy, toxicity, target validation, and multi-cancer screening services for pharmaceutical, biotechnology, and research organizations, enabling clients to evaluate drug candidates, validate therapeutic targets, and accelerate preclinical oncology research.
Contact Information
Website
www.inovotion.comCorporate Office
- 5 Avenue du Grand Sablon
- 38700 La Tronche
- France
Corporate Office
- 5 Avenue du Grand Sablon
- 38700 La Tronche
- France
Inovotion Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 01-Apr-2024 | Completed | Generating Revenue | |||
| 6. Angel (individual) | 07-Nov-2017 | Completed | Generating Revenue | |||
| 5. Grant | 17-Oct-2016 | Completed | Generating Revenue | |||
| 4. Angel (individual) | 09-Aug-2016 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Angel (individual) | Completed | Generating Revenue | ||||
| 1. University Spin-Out | 01-Jan-2014 | Completed | Generating Revenue |
Inovotion Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
Inovotion Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Inovotion Patents
Inovotion Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4520331-A1 | Pharmaceutical composition comprising trpv4 inhibitor for use in the prevention or treatment of cerebral cavernous malformations (ccm) | Inactive | 08-Sep-2023 | ||
| WO-2025051930-A1 | Pharmaceutical composition comprising trpv4 inhibitor for use in the prevention or treatment of cerebral cavernous malformations (ccm) | Inactive | 08-Sep-2023 | ||
| AU-2019373749-A1 | Animal model for amplifying human or animal circulating tumor cells | Active | 29-Oct-2018 | ||
| AU-2019373749-B2 | Animal model for amplifying human or animal circulating tumor cells | Active | 29-Oct-2018 | ||
| CA-3118200-A1 | Animal model for amplifying human or animal circulating tumor cells | Pending | 29-Oct-2018 | A01K67/0271 |
Inovotion Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Inovotion Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Grenoble INP - UGA Recrutement | University |
Inovotion FAQs
-
When was Inovotion founded?
Inovotion was founded in 2014.
-
Where is Inovotion headquartered?
Inovotion is headquartered in La Tronche, France.
-
What is the size of Inovotion?
Inovotion has 15 total employees.
-
What industry is Inovotion in?
Inovotion’s primary industry is Discovery Tools (Healthcare).
-
Is Inovotion a private or public company?
Inovotion is a Private company.
-
What is Inovotion’s current revenue?
The current revenue for Inovotion is .
-
How much funding has Inovotion raised over time?
Inovotion has raised $1.03M.
-
Who are Inovotion’s investors?
Grenoble INP - UGA Recrutement has invested in Inovotion.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
